Article Text

Download PDFPDF

Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation
  1. J A Montero1,
  2. J M Ruiz-Moreno1,2
  1. 1Instituto Oftalmológico de Alicante, Vitreo-Retinal Unit, Alicante, Spain
  2. 2Department of Ophthalmology, Miguel Hernández University School of Medicine, Alicante, Spain
  1. Correspondence to: Javier A Montero, Instituto Oftalmológico de Alicante, Avenida de Denia 111, 03015, Alicante, Spain; msm02va{at}wanadoo.es

Abstract

Aims: To analyse the visual and angiographic results of photodynamic therapy (PDT) with verteporfin in highly myopic patients with subfoveal choroidal neovascularisation (CNV).

Methods: PDT was performed on highly myopic patients with subfoveal CNV. The patient population was divided into two groups according to age at onset of CNV (group 1 aged ≤ 55 and group 2 aged >55 years old). Best corrected visual acuity (BCVA) and angiographic findings were considered.

Results: At the end of follow up group 2 had worse BCVA than group 1. 76% of patients in both groups showed a complete closure of CNV at the end of follow up.

Conclusion: Visual prognosis of myopic CNV treated by PDT is influenced by age at onset.

  • myopia
  • choroidal neovascularisation
  • photodynamic therapy
View Full Text

Statistics from Altmetric.com

Footnotes

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.